Abstract Measurement of areal bone mineral density (aBMD) in intravertebral subregions may increase the diagnostic sensitivity of dual-energy X-ray absorptiometry (DXA)-derived parameters for vertebral fragility. This study investigated whether DXA-derived bone parameters in vertebral subregions were better predictors of vertebral bone strength in specimens with low aBMD, compared to those with higher aBMD. Twenty-five lumbar vertebrae (15 embalmed and 10 fresh-frozen) were scanned with posteroanterior-(PA) and lateral-projection DXA, and then mechanically tested in compression to ultimate failure. Whole-vertebral aBMD and bone mineral content (BMC) were measured from the PA-and lateral-projection scans and within 6 intravertebral subregions. Multivariate regression was used to predict ultimate failure load by BMC, adjusted for vertebral size and specimen fixation status across the whole specimen set, and when subgrouped into specimens with low aBMD and high aBMD. Adjusted BMC explained a substantial proportion of variance in ultimate vertebral load, when measured over the whole vertebral area in lateral projection (adjusted R 2 0.84) and across the six subregions (ROIs 2-7) (adjusted R 2 range 0.58-0.78). The association between adjusted BMC, either measured subregionally or across the whole vertebral area, and vertebral failure load, was increased for the subgroup of specimens with identified 'low aBMD', compared to those with 'high aBMD', particularly in the anterior subregion where the adjusted R 2 differed by 0.44. The relative contribution of BMC measured in vertebral subregions to ultimate failure load is greater among specimens with lower aBMD, compared to those with higher aBMD, particularly in the anterior subregion of the vertebral body.
Introduction
It is well established that bone microstructure and quantity are distributed heterogeneously throughout the vertebral body [1] [2] [3] [4] [5] [6] [7] [8] , and that variance in these distributions influences bone strength [7] [8] [9] [10] [11] and responses to bisphosphonate therapy [12] . The intravertebral distribution of bone microstructure and quantity is, therefore, likely to have important implications for the mechanisms underlying vertebral fracture [13] [14] [15] [16] . We have previously undertaken research to establish the precision and accuracy of a subregional bone mineral density (srBMD) measurement method [2, 3, 6] and its application in the clinical setting [14, 17] . Comparing differences in srBMD values between individuals may be confounded by the variability in their bone size. However, this variability can be overcome by comparing the ratios of srBMD values (that is the ratio of one subregion to another within the same vertebral body) among individuals, rather than their absolute aBMD values. Using ratios of srBMD to compare between individuals removes the potentially confounding influence of differences in the sizes of the vertebrae, and as such of the subregions, between individuals. Our preliminary clinical data suggest that there is little difference in the ratios of srBMD between individuals with normal areal bone mineral density (aBMD) and those with primary osteoporosis, inferring there is a general, homogeneous vertebral bone loss associated with primary osteoporosis, not confined to a preferential subregional area within the vertebra. However, we have observed selective subregional bone loss among individuals with glucocorticoid-induced osteoporosis (GIO) [17] , which may suggest selective subregional vertebral bone loss in specific disease states, such as in GIO, or a change in selectivity in individuals with advanced disease states. It is warranted, therefore, to explore the contribution of subregional vertebral bone mineral measures in predicting vertebral failure in differing states of vertebral bone loss.
While generally less precise than posteroanterior (PA)-projection scans, bone mineral measurements derived from the lateral-projection scans may have the potential to improve fracture prediction estimates. Despite the general low acceptance of lateral-projection scanning, largely attributed to poorer precision and relative lack of reference data, a web of evidence points to the potential clinical utility of bone mineral data derived from the lateral-projection scans compared to the PA-projection scans, including a stronger association with vertebral failure strength [18, 19] , superior diagnostic sensitivity [14, [20] [21] [22] [23] and greater sensitivity to changes in bone mineral measurements with therapy [24] [25] [26] [27] or ageing [21] . However, despite greater sensitivity to changes in bone mineral measurements with therapy, Blake et al. [24] concluded that PA-projection measures are the most suitable for longitudinal studies. Further, Bjarnason et al. [28] also identified that while lateral-projection scanning had a diagnostic advantage in vitro, consistent with more recent data [18, 19] , this diagnostic advantage was not sustained in situ due to a lower ratio of bone to soft tissue in the lateral-projection mode. Ultimately, the choice of scanning projection revolves around the balance between sensitivity in fracture prediction on the one hand and measurement precision on the other hand. For example, an added advantage of the lateral-projection approach is the ability to measure aBMD in vertebral subregions [2, 3] , which may improve measurement specificity for X-ray absorptiometry (DXA), and ultimately improve fracture risk prediction [3] , particularly in patients with GIO [17] . In this study, we have chosen to explore whether sensitivity can be enhanced using subregional bone mineral measures derived from the lateral-projection scans. If successful, this methodological development could lead to a reappraisal of the diagnostic utility of lateral spine scanning.
The aim of this study was to examine the relationship between subregional bone mineral content (BMC) derived from lateral-projection DXA from the human cadaveric spine specimens and vertebral failure strength determined experimentally. We hypothesised that, in vertebrae with more advanced bone loss, subregional BMC measurements would more strongly predict vertebral body strength compared to specimens with less advanced bone loss.
Materials and Methods

Specimens
The imaging and mechanical testing procedures used in this study have been reported in detail elsewhere [2, 3, 18] , and are described briefly below. Twenty-five vertebral bodies (L2-L4), derived from a set of 10 embalmed and 5 fresh-frozen cadaver spines (7 male, 8 female; mean (SD) age at death 78.2 (9.6) years), were available for analysis in this study (Table 1 ). The 10 embalmed donor cadavers were fixed with 20-40 L of embalming fluid (55 % ethanol, 5 % formaldehyde, 5 % phenol, 20 % propylene glycol and 15 % water) and stored at 4°C for 3 months prior to harvesting of the spine. Previous investigators have found no effect of formalin fixation on vertebral BMD estimations by DXA on embalmed specimens compared to fresh specimens [29] . Therefore, data derived from fresh and embalmed specimens were pooled when examining vertebral bone mineral distributions across the sample (see 'Data Analysis' section). The 5 fresh-frozen specimens were frozen at -17°C. In all specimens, the ribs and ilia were removed from the spine segments leaving intact vertebral bodies and connective tissues. Embalmed specimens were sealed in water-tight shrink wrap thermoplastic, while fresh-frozen specimens remained in gauze wrap. Prior to any scanning, lateral radiographs were acquired from each specimen to screen for vertebral fractures and any other overt bone pathology, and to verify vertebral levels in conjunction with a PA-projection DXA image. Fresh-frozen specimens were scanned in a frozen state, removed from the freezer just before the commencement of scanning.
Each specimen was scanned using DXA and subsequently mechanically tested to failure. Dual-Energy X-ray Absorptiometry (DXA) All scannings were performed using a Hologic (Hologic Inc., Bedford, MA; USA) QDR4500A fan beam densitometer, with a spatial resolution of 1.0 mm, with running operating software version 9.10D. Spine samples were placed supine in a water bath (270 9 180 9 150 mm) of tap water to a depth of 18 cm to simulate soft tissue composition in vivo. This procedure has been used in previous ex vivo studies with validity and reliability established for both lumbar and thoracic vertebrae [19, [30] [31] [32] [33] . A matched PA-supine lateral scan pair was acquired on each specimen using the array scanning mode. Each lateral scan was performed with a fixed scan length of 15.32 cm and width of 14.47 cm and pixel size of 1.007 mm. At the completion of the lateral scan, both a standard analysis and a customised subregional analysis were performed. Areal BMD was calculated for the whole vertebral body area (defined as a region of interest (ROI) 1) and within six subregions: three oriented sagittally (ROIs 2-4) and three transversely (ROIs 5-7) (Fig. 1) . Subregions were created manually by modifying the regions of interest during the analysis phase. The whole vertebral area (ROI 1) was defined by the four corners of the vertebra of interest from the lateral DXA image, including the vertebral endplate and excluding the posterior elements. Overt osteophytes were excluded from the ROIs and deleted from the bone map manually, in agreement with previous work [31, 34, 35] . The size and shape of ROI 1 were defined according to the morphology of the vertebral body. The endplates defined the superior and inferior margins, the anterior border of the centrum defined the anterior margin, while the posterior margin was defined by the junction between the vertebral centrum and pedicle of the posterior elements. Subregions 2-4 formed equal thirds in the area of ROI 1, oriented sagittally. Subregions 5-7 formed equal thirds in area of ROI 1, oriented transversely. Our pilot data demonstrate good to fair short-term precision of this protocol, when applied at L2 and L3 ex vivo (% CV range 1.8-6.8 %) [36] . We have also established acceptable precision of the subregional measurement protocol in an in vivo context [6] . Measurement of Vertebral Geometry
The absolute vertebral height was measured by digitising vertebral dimensions visible on the lateral DXA scan. Digital images of the lateral DXA scan were imported into image processing software (Image J version 1.30, National Institute of Health, Maryland, USA). Images were digitised to extract Cartesian x, y coordinates of corners of each vertebral body. After correcting for rotation, x, y coordinates were transformed into real dimensional units (mm) to determine vertebral height.
Mechanical Testing
After DXA scanning, the vertebral bodies were mechanically tested to failure. The specimen preparation and testing procedure were performed based on previously published protocols [18, 37, 38] . On both the endplates, a 3-mm-thick layer of polymethylmethacrylate (PMMA) was applied, by submerging the vertebra into a curing PMMA mixture. The specimens were soaked for 12 h in saline solution at room temperature for rehydration [18, 19] , before being placed in the mechanical testing machine (Model 800L, TestResources Inc, Shakopee, MN, USA). The uniaxial compression tests were performed between steel platens with a lockable ball joint to ensure planoparallel ends [18, 37] . A saline-soaked gauze was used to keep the specimens moist during the experiment, which was done at room temperature. After preconditioning (5 cycles, at 0.1 Hz, between 150 and 350 N, then held at 250 N for 5 min), the specimens were tested in displacement control at a rate of 0.15 mm/s [18, 37, 38] . The displacement was measured by a transducer (Linear Variable Differential Transformer) attached to the cross-head. Vertebral body strength (F ult , expressed in kN) was defined as the peak load during the compressive loading (i.e. the ultimate load). The compressive stiffness (kN/mm) was also calculated, as the slope of the linear portion of the load-displacement curve, between 25 and 75 % of the failure load [39] . The deformation to failure was calculated from the load-displacement curve, by extrapolating the linear elastic portion back to zero load and expressed as a percentage of the original specimen height.
Data Analysis
Descriptive statistics were used to summarise specimen densitometric characteristics and mechanical properties. Mechanical properties were compared between embalmed and fresh-frozen specimens using a one-way ANOVA, including models where parameters were adjusted for vertebral height. A repeated measures ANOVA was performed to evaluate differences in aBMD and BMC between subregions, in keeping with earlier work [2, 3, 14, 17, 30] . Given this was a within-specimen analysis and that fixation does not influence DXA-measured BMD [29] , data from embalmed and fresh-frozen specimens were pooled in the ANOVA models, as performed previously [2] . While there were seven regions of interest (ROIs), the withinsubject factor (ROI) was set a priori at k=4 to ensure that overlapping subregions were not compared post hoc. That is, sagitally oriented subregions were not compared with transversely oriented subregions in the same ANOVA model. Therefore, the first ANOVA model included ROIs 1-4, and the second ANOVA model included ROIs 1 and 5-7. Bonferroni adjustments were applied to pairwise comparisons to account for multiple tests. Multivariate regression models were used to quantify the association between ultimate vertebral failure load (dependent variable) and BMC (predictor variable), adjusted for vertebral height and specimen fixation status. Vertebral height was included in the model as an index of vertebral size, as it is a relatively simple measurement and can be directly measured from the DXA scans [3] , and has been used previously in multiple regression models for this purpose [40] . Due to the inclusion of an index of vertebral size in the regression models, BMC, rather than aBMD, was used as the predictor variable. While formalin fixation does not appear to systematically affect bone mineral measurements, it has been shown to influence compressive strength of vertebral bone [29] . Hence, specimen fixation status was included as a nominal variable in multiple regression models. Multivariate models were run for a pooled sample of 25 vertebrae and for two subgroups of vertebrae categorised as 'low aBMD (n = 13)' and 'high aBMD (n = 12)', based on a median split of lateral-projection aBMD values of the ROI 1 at 0.458 g/cm 2 . The aBMD data calculated for ROI 1 were normally distributed. For all regression models, adjusted R 2 values were used as the index to quantify strength of association. Data were analysed using IBM SPSS Statistics 19, IBM Corporation. 
Results
Descriptive
(2.1) g and 5.6 (1.8) g, respectively; -0.8 [-2.5, 0.9] g) projections.
Subregional aBMD and BMC Profiles
A main effect for ROI was observed when comparing aBMD and BMC between sagittal and transverse ROIs (p \ 0.0001). In the sagittal ROI analysis, a significant difference was observed between all ROIs for aBMD (p B 0.004; Fig. 2 ) and BMC (p \ 0.0001; Fig. 3 ). The highest aBMD was observed in the posterior subregion (ROI 2), while the lowest aBMD was observed in the anterior subregion (ROI 4). When considering only the intravertebral subregions, the same distribution pattern was observed for BMC profiles. In the transverse ROI analysis, a significant difference was observed between all ROIs for aBMD (p B 0.006; Figure 2 ), other than between whole (ROI 1) and superior (ROI 5) regions (p = 0.11). For BMC, a significant difference was observed between all subregions (p B 0.0001; Fig. 3 ), other than between the superior (ROI 5) and inferior (ROI 7) subregions. The highest aBMD was observed in the inferior subregion (ROI 7), while the lowest aBMD was observed in the central subregion (ROI 6). Table 2 provides a summary of mechanical parameters measured. Mean ultimate vertebral failure load (F ult ) and vertebral height-adjusted mean ultimate failure load did not exhibit statistically significant differences between embalmed and fresh-frozen specimens. Mean vertebral stiffness was significantly higher and mean relative ultimate deformation was significantly lower, in the embalmed specimens.
BMC as a Predictor of Ultimate Vertebral Failure
Multivariate regression models with adjusted BMC as the predictor, explained a substantial proportion of variance in the ultimate vertebral load, where BMC was measured over the whole vertebral area in lateral projection (ROI 1; adjusted R 2 0.84) and across the six subregions (ROIs 2-7) (adjusted R 2 range: 0.58-0.80; p \ 0.0001). BMC derived from lateral-projection DXA, measured across the whole vertebral area (ROI 1) or within a subregion (ROIs 2-7), accounted for a substantially greater proportion of variance in ultimate load, compared to BMC derived from PA projections ( Table 2 ). Both vertebral height and fixation status remained significant covariates across most multivariate models, other than the high aBMD subgroup where vertebral height was not a significant predictor of failure load (Table 3) .
Across all the specimens, subregional BMC (ROIs 2-7) was not a stronger predictor of ultimate vertebral failure load than BMC measured across the whole vertebral area (ROI 1) (Table 3) . However, when analysed in aBMD subgroups, subregional BMC accounted for a greater proportion of variance in ultimate vertebral failure load in the low aBMD subgroup, compared to the high aBMD subgroup (mean increase in variance explained: 18 %). This was particularly noticeable for the change in adjusted R 2 at ROIs 4, 6 and 7, where the adjusted R 2 values increased by 0.44, 0.15 and 0.24, respectively, compared to the high aBMD group (Fig. 4) . Within the low aBMD subgroup, BMC measured at ROIs 4 and 7 explained a greater proportion of variance in ultimate vertebral load than BMC measured at ROI 1, although not by a clinically meaningful amount. Similar to the multivariate regression models using the whole dataset, measures of BMC derived from lateral-projection DXA, either whole vertebral (ROI 1) or subregional (ROIs 2-7), explained a greater proportion of variance in ultimate load than BMC derived from PAprojection DXA (Table 3) .
Discussion
Consistent with previous investigations, this study confirms that vertebral aBMD and BMC measured by lateral-projection DXA vary within the vertebral body [3, 13, 22] . In accordance with the existing literature [18, 19, 33, 41] , BMC was found to be a strong predictor of ultimate vertebral failure load, and a substantially greater proportion of variance in failure load could be explained by BMC when measured using lateral-projection DXA, compared with PA-projection DXA (e.g. R 2 = 0.86 vs. 0.57). This finding supports the potential for broader application of lateralprojection DXA in clinical settings. Moreover, when subgrouping our cohort into vertebrae with lower and higher aBMD, variations in vertebral failure load were better explained by adjusted BMC values for specimens with lower aBMD. In particular, for subregional BMC measures, vertebrae with lower aBMD exhibited stronger correlations (R 2 up to 0.88) with failure load, compared to vertebrae with higher aBMD (R 2 up to 0.72). Although, when compared to lateral BMC measures derived from the whole vertebral body (R 2 = 0.84), the increase in R 2 value due to subregional BMC measures unlikely represents a clinically meaningful improvement in magnitude, our data highlight the potential biological and biomechanical role of subregional BMC in influencing vertebral fragility in circumstances of low aBMD.
Differences in aBMD and BMC between subregions demonstrated in this study are comparable to those we have observed in clinical [6, 17] and ex vivo [30] studies previously. It is most likely that the patterns of distribution of subregional bone mineral properties influence the mechanical behaviour of the vertebral body, particularly the relative distributions between subregions. For example, DXA-derived aBMD and BMC are lower in the anterior and central subregions, compared to other regions such as the posterior region and regions adjacent to the endplates. This observation is likely due to the relatively lower amount of bone present in these regions, particularly in the central region (ROI 6) as shown in our previous studies using pQCT [3, 22] and may point to a mechanism underlying vertebral anterior wedge fractures [42] . The profiles of subregional aBMD and BMC appear to be consistent across ex vivo studies [2, 14] , consistent across imaging modalities [3] and consistent between individuals with normal aBMD and BMC and those with primary osteoporosis, suggesting non-selective vertebral bone loss. We demonstrated recently that the vertebral subregional aBMD distribution profile appears to differ among individuals with GIO [17] , suggesting selective vertebral bone loss in specific vertebral subregions, particularly ROI 4. Although this finding needs verification in larger studies with multiple patient groups, it does provide a rationale that subregional bone distribution measured by DXA may have important biological significance to vertebral strength in specific patient groups, and/or in vertebrae with advanced bone loss. Indeed, the results from this study highlight that subregional BMC is a stronger predictor of vertebral failure load in a group of specimens presenting with lower aBMD values compared to specimens with high aBMD. This finding was particularly evident in the anterior subregion, where a further 44 % of variance in failure load was explained in samples with low aBMD compared to high aBMD. The strong relationship between BMC measured in the anterior subregion with vertebral failure load in specimens with low aBMD is likely related to the extent of intervertebral disc degeneration. Earlier studies have demonstrated an association between disc degeneration and relative increased bone loss in the anterior region of the vertebral body [5, 42] , which is likely to lead to increased propensity to vertebral body failure. We are unable to speculate further on these associations, as we have no data regarding disc degeneration in our specimen sample. However, this represents an important consideration for future research.
While we acknowledge that the proportion of variance explained by subregional measures of BMC (ROI 4) was only up to 4 % greater than that explained by BMC measured from the whole vertebral body, the finding is consistent with previous work [9] . Moreover, the difference in R 2 values between multivariate models using high aBMD samples compared to low aBMD samples was substantially greater for the subregions (0.03-0.44), compared to the whole-vertebral BMC (0.11), demonstrating an increasing contribution of subregional BMC to influence vertebral failure as bone loss progresses. Here, the relative importance of subregional bone mineral measures may be related to progressively selective bone loss [43] , influenced, for example, through intervertebral disc degeneration [5] .
Our data suggest that BMC measured in the superior and inferior ROIs (ROIs 5 and 7) has a more substantial role in determining vertebral strength in uniaxial compressive testing, compared to BMC derived from the central ROI (ROI 6), pointing to a critical role of the bone in the superior and inferior zones of the vertebral body in modulating vertebral failure in compression. This observation was consistent across specimens with high and low aBMD and concurs with results from lCT-based finite element modelling by Eswaran et al. [44] and Homminga et al. [45] .
This study had several important strengths. First, although the likely importance of subregional bone mineral properties in modulating vertebral failure load has been noted previously for BMD [9] and bone volume fraction [10] particularly in the anterior region, measurements of bone mineral properties in this area using DXA and linking them to failure load have not previously been explored. Second, we mechanically tested a large sample of vertebrae, which allowed us to undertake subgroup analyses based on a median split of aBMD values. Third, we examined the association between failure load and BMC using multivariate models, accounting for the potentially confounding influence of specimen fixation and vertebral size. Moreover, the standardised regression coefficients reported in this study are comparable to those reported previously by Edmondston et al. [40] . Some important limitations should be considered in the interpretation of our results. First, the loading condition we applied to the vertebrae is not completely representative of physiologic conditions. Although compression in inferior-superior direction is the predominant loading direction in upright stance on the lumbar spine [46] , the experimental protocol used in the study does not account for other forces or moments the vertebrae would experience in vivo, such as bending moments. More importantly, the significant role of the intervertebral disc in transferring load across the vertebral body is not considered in our protocol, nor the influence of disc degeneration on load transmission across the vertebral body and the likely secondary consequences of altered load transmission on subregional bone mineral properties [5, 7, 42] . Second, we chose to employ DXA as the imaging modality in this study owing to its ubiquitous use in the clinical environment. Consequently, our inferences regarding the relationship between BMC and load are limited to composite measures of trabecular and cortical bone, and do not enable us to explore the important contributions of these bone components independently [18] , or the contribution of subregional bone microarchitecture to mechanical behaviour [39] . Further, matched PA-lateral scans are only available with Hologic densitometers. While other manufacturers enable acquisition of lateral-projection scans, a decubitus position is generally required, which is associated with unacceptably low precision and substantially longer operator time. Third, the experimental protocol involving a water bath to acquire DXA scans does not truly correspond with the clinical environment, where scan artefacts attributed to variance in soft tissue composition of the trunk and arterial calcification are commonplace. Finally, when considering our pooled sample of 15 ), based on the aBMD values reported by Henry et al. [47] (average values below -2.5 SD). When subgrouped, donors in the low aBMD fell in the osteoporosis range (PA aBMD values below -2.5 SD), while those in the high aBMD fell in the osteopenic range (PA aBMD values between -1 and -2.5 SD). This, together with the advanced age, suggests that subjects sampled in our study might generally represent a subgroup with an increased risk of fracture compared to the normal population. Importantly, these estimates have been calculated by adjusting our raw data for scanner type [48] and for data derived from ex situ scanning, where values are recommended to be lowered by 10 % to be compared to in situ scanning [49] , consistent with an approach we have reported previously [18] .
Given the expanding web of knowledge surrounding the potential biological significance of measuring subregional bone mineral properties with lateral-projection DXA, it will now be important to verify lab-based findings with further clinical studies to elucidate changes in subregional bone properties over time and in response to therapies. It will also be important to verify the associations between subregional bone mineral properties and mechanical behaviour of whole vertebral bone using experimental loading conditions, which more closely replicate physiologic loading. Ultimately, clinical studies that compare fracture prediction by different DXA modalities will be important.
Conclusion
BMC measured from lateral-projection DXA, either across the whole vertebral area or within vertebral subregions, is a stronger predictor of failure load than BMC measured from PA-projection DXA. The relative contribution of BMC measured in vertebral subregions to ultimate failure load is substantially greater among specimens with lower global aBMD, particularly in the anterior subregion of the vertebral body, as opposed to those with high aBMD. In specimens with low aBMD, BMC measured from the anterior subregion accounts for a slightly greater proportion of variance in vertebral failure load than a measure of wholevertebral BMC.
